Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Novel lung cancer vaccine CV-9202 evaluated in phase I trial

Aug. 23, 2013

Generation of a human anticancer immune response using a dendritic cell-based vaccine

Aug. 22, 2013

MacroGenics doses first patient in phase I MGA-271 trial

Aug. 21, 2013

Patient enrolled in brain tumor vaccine trial at Northwestern Memorial Hospital

Aug. 19, 2013

Amorfix Life Sciences provides update on ovarian cancer program

Aug. 19, 2013

ADXS-HPV receives orphan drug designation for HPV-associated anal cancer

Aug. 19, 2013

Phase II trial of Adcetris in combination with standard of care for frontline DLBCL commences

Aug. 19, 2013

Altor receives IND clearance to advance ALT-803 into clinical trials in melanoma

Aug. 16, 2013

Patrys discloses additional data from phase I/II trial of PAT-SM6 in MM

Aug. 16, 2013

Immunomedics advances solid tumor ADC programs to phase II

Aug. 13, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...